Financial Comparison: Fortress Biotech


Transition Therapeutics and Fortress Biotech are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, profitability, risk and earnings. 12.1% of Fortress Biotech shares are owned by institutional investors.



from Biotech News